CME Group (NASDAQ:CME – Get Free Report) is anticipated to post its Q3 2026 results before the market opens on Wednesday, October 21st. Analysts expect the company to announce earnings of $2.98 per share and revenue of $1.71 billion for the quarter. Interested persons can find conference call details on the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Wednesday, October 21, 2026 at 8:30 AM ET.
CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%. The company’s quarterly revenue was up .8% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.96 EPS. On average, analysts expect CME Group to post $12.30 EPS for the current fiscal year and $12.88 EPS for the next fiscal year.
CME Group Stock Performance
Shares of CME Group stock opened at $293.53 on Tuesday. The company has a market cap of $105.55 billion, a PE ratio of 24.90, a price-to-earnings-growth ratio of 3.80 and a beta of 0.24. CME Group has a 52 week low of $218.31 and a 52 week high of $329.16. The business has a 50 day moving average price of $274.72 and a 200-day moving average price of $270.56. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.
CME Group Announces Dividend
Insider Buying and Selling
In other CME Group news, CEO Terrence Duffy sold 15,000 shares of the firm’s stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $274.44, for a total value of $4,116,600.00. Following the completion of the transaction, the chief executive officer owned 40,630 shares in the company, valued at $11,150,497.20. This trade represents a 26.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Elizabeth Cook sold 500 shares of CME Group stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $280.11, for a total value of $140,055.00. Following the transaction, the director directly owned 17,916 shares of the company’s stock, valued at $5,018,450.76. The trade was a 2.72% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is currently owned by insiders.
Trending Headlines about CME Group
Here are the key news stories impacting CME Group this week:
- Positive Sentiment: Earnings expectations remain supportive. Analysts expect third-quarter revenue of approximately $1.71 billion, up 11.4% year over year, with earnings per share near $2.98. Forecasts also point to 22% growth in international trading volume, and several analysts have raised price targets ahead of the report. Is a Beat in the Cards for CME Group This Earnings Season? CME Group Earnings Are Imminent
- Positive Sentiment: New cryptocurrency futures broaden CME’s product lineup. CME has targeted an Oct. 19 launch for standard and micro Bitcoin Cash and Uniswap futures, giving institutions regulated tools to hedge or gain exposure without holding the underlying tokens. The launch could increase fee opportunities, although actual demand and regulatory clearance remain key factors. CME Targets October 19 Start For Bitcoin Cash And Uniswap Futures
- Positive Sentiment: CME plans tungsten futures. The proposed contracts would address rising demand for critical-minerals exposure and expand CME’s metals franchise, which has experienced record trading volume. The initiative could create another source of trading activity and revenue. CME to Launch Tungsten Futures
- Neutral Sentiment: Legal uncertainty persists around crypto derivatives. The Commodity Futures Trading Commission has asked a federal court to dismiss CME’s lawsuit concerning crypto perpetual futures. The outcome could affect CME’s ability to offer or defend certain products, but the immediate financial impact is unclear. CFTC Asks Court to Dismiss CME Group Lawsuit
Analyst Ratings Changes
A number of research analysts have issued reports on CME shares. TD Cowen upped their price objective on CME Group from $292.00 to $300.00 and gave the company a “buy” rating in a research note on Monday, October 5th. Barclays increased their price target on shares of CME Group from $270.00 to $281.00 and gave the company an “equal weight” rating in a research report on Wednesday, October 7th. Deutsche Bank Aktiengesellschaft downgraded shares of CME Group from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $286.00 to $270.00 in a report on Wednesday, August 19th. Morgan Stanley lifted their price objective on shares of CME Group from $330.00 to $337.00 and gave the stock an “overweight” rating in a research report on Friday, October 9th. Finally, Weiss Ratings raised shares of CME Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $292.94.
Read Our Latest Stock Report on CME Group
About CME Group
CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.
CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.
Featured Stories
- Five stocks we like better than CME Group
- Tesla’s Roadster Reveal Hints at 2 Much Bigger Moves
- The AI Sell-Off Continues—These 3 Stocks Keep Raising Guidance Anyway
- Mr. Wonderful’s Test for AI Data Center Stocks: Power, Permits, and Tenants
- Alcoa Beat Earnings, But Can It Escape the Aluminum Bears?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
